MICHELLE DAVIS: Open Payments
NPI 1487103719 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,653 in 120 payments from 19 companies in 2025. Trend: 2023 $1,702 · 2024 $2,594 · 2025 $2,653
Food & beverage: $2,568Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $501 |
| GENZYME CORPORATION | 14 | $409 |
| Regeneron Healthcare Solutions, Inc. | 8 | $245 |
| LEO Pharma Inc. | 9 | $229 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 15 | $229 |
| UCB, Inc. | 11 | $224 |
| Galderma Laboratories, L.P. | 9 | $143 |
| Novartis Pharmaceuticals Corporation | 6 | $140 |
| Organon LLC | 13 | $122 |
| PFIZER INC. | 4 | $87 |
Products named: DUPIXENT, SKYRIZI, RINVOQ, Bimzelx, ADBRY, NEMLUVIO, COSENTYX, VTAMA.
Industry payments across AZ — which companies pay providers there.
